Best Life Sciences Tech Companies in Pennsylvania, United States
The 127 best Life Sciences Tech companies in Pennsylvania, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Aprecia Pharmaceuticals.
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Tech companies in Pennsylvania
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Aprecia Pharmaceuticals Develops & manufactures orodispersible formulations of highly prescribed high-dose medications using… | $176M | 119 mo ago | 87 87 → 65 (-25%) | Owen Murray CEO | WordPressApple iCloud MailMySQL+25 | Top 50M | — | — |
| 2 | iECURE Online genetic engineering tool for drug development | $115M | 42 mo ago | 7 | Joseph Truitt CEO | — | — | — | 1 internship |
| 3 | Proscia Provider of an AI and cloud-based digital pathology solution for cancer diagnosis | $79M | 15 mo ago | 85 85 → 132 (+55%) | Nathan Buchbinder Co-Founder & Chief Strategy Officer | WordPressApple iCloud MailGoogle Workspace+33 | Top 5M | 64 patents AI-driven image analysis and workflow automation for digital pathology diagnostics | — |
| 4 | Novasenta Developer of a drug discovery platform for cancer therapies | $55M | 29 mo ago | 20 | Dario Vignali Co-Founder | — | — | 4 patents Therapeutic antibodies targeting CD161 for immunomodulation and disease treatment | — |
| 5 | Suvoda Provider of clinical trial management solution | $40M | 78 mo ago | 302 | Jagath Wanninayake Co-founder | HubSpot CMS HubSentryApple iCloud Mail+26 | Top 500k | 18 patents Customizable SaaS platforms with AI conversational assistants and interactive document generation | — |
| 6 | Octagon Research Provider of clinical and regulatory information management software | $39M | 213 mo ago | 406 | — | — | — | — | — |
| 7 | RIMSYS Provider of medical device regulatory management software for healthcare organizations | $26M | 26 mo ago | 31 31 → 31 (+0%) | James Gianoutsos Founder & President | WebflowApple iCloud MailMicrosoft 365+25 | Top 10M | — | 1 launch |
| 8 | Invivodata Provider of patient data collection and data management software | $25M | 196 mo ago | 32 | — | — | — | 14 patents Digital platforms for clinical trial data capture, monitoring, and subject compliance management. | — |
| 9 | Lathian Systems Multichannel marketing specialists connecting healthcare providers with life science companies | $14M | 303 mo ago | — | Quang Pham Founder | — | — | — | — |
| 10 | Meta Pharmaceutical Services Integrated Marketing Communications for Pharmaceutical industry | $14M | 155 mo ago | 110 | Natalie Kitchell Co-Founder & President | — | — | — | — |
| 11 | Progenra Developing innovative therapeutics targeting protein degradation for challenging diseases | $12M | 13 mo ago | 13 | Tauseef Butt President and CEO | — | — | 38 patents USP7-targeted small‑molecule inhibitors for cancer therapy and immune modulation | — |
| 12 | Y-Prime Provider of software solutions for conducting clinical trials | $12M | 88 mo ago | 275 275 → 276 (+0%) | — | WordPress Block EditorWordPressApple iCloud Mail+41 | Top 10M | 21 patents Clinical trial risk prediction platform and secure data reader; rotary fan press technology. | — |
| 13 | Pharma Solutions Provider of compliance automation software for pharmaceutical industries 45Moat top 28%Patents top 33%Growth top 35%Innovation top 41% All 9 signals ▾Moattop 28% Patentstop 33% Growthtop 35% Innovationtop 41% Fundingtop 42% Talentbottom 49% Techbottom 46% Globalbottom 35% Marketbottom 34% Moat: Editorial + unicorn rating 4/10 · IP moat: 248 patents Patents: 248 patents matched (strict assignee match) · 33 filings since 2022 vs 99 in 2017-21 rank vs industry peers · Fliar Intelligence Index 45/100 | $7M | 2 mo ago | 43 | Sumeet Singh Founder & CEO | WordPressMySQLPHP+29 | Top 50M | 248 patents Oral zirconium silicate potassium binders for hyperkalemia treatment | — |
| 14 | CluePoints Provider of AI-based software for risk-based monitoring and data quality oversight for clinical trial studies | $7M | 69 mo ago | 86 | Marc Buyse Co-Founder | WordPressApple iCloud MailMicrosoft 365+33 | Top 5M | — | — |
| 15 | HueDx Provider of a cloud-based diagnostic platform for clinicians | $7M | 70 mo ago | 10 | Brianna Wronko Founder & CEO | — | — | 14 patents Microfluidic point‑of‑care diagnostic assays with integrated optical color‑correction technology | 1 launch |
| 16 | CFS Clinical Investigator site payment and study startup solutions | $6M | 264 mo ago | 28 | Ibraheem Mahmood CEO | — | — | — | — |
| 17 | Greenphire Clinical trial technology simplifying the journey for patients, sites, and sponsors | $6M | 108 mo ago | 259 259 → 194 (-25%) | John Samar Chief Financial Officer & Founder | WordPress Block EditorWordPressMySQL+17 | Top 5M | 18 patents Clinical trial logistics and data management platforms for participant privacy and workflow automation | — |
| 18 | Panorama Medicine Provider of drug discovery platform for detecting RNA defects | $6M | 33 mo ago | 5 | — | — | — | — | — |
| 19 | ThirdLaw Molecular Drug discovery platform developing peptide molecules | $6M | 9 mo ago | — | Christian Schafmeister Founder | — | — | — | — |
| 20 | BioPhy Provider of AI operating system that accelerates the identification and development of the most promising… | $4M | 15 mo ago | — | Daniel Sciubba Co-Founder | — | — | — | — |
| 21 | Signant Health Provider of a software solution for clinical trial management | $3M | 93 mo ago | 2,032 | Roger Smith CEO | HubSpot CMS HubBugHerdSalesforce+27 | Top 500k | — | 1 launch |
| 22 | Melior Discovery Develops pharmacology platform to identify pre-clinical and development stage drug candidates | $3M | 141 mo ago | 29 | Andrew Reaume President & CEO | WordPressMySQLPHP+23 | Top 10M | 50 patents Small-molecule drugs for treating dyskinesia and related neurological movement disorders | — |
| 23 | Xbio Systems Suite Solutions for drug development, clinical trial management | $3M | 228 mo ago | — | Steven Godinho CEO | — | — | — | — |
| 24 | Viihealth Customer Engagement & Digital Solutions Company dedicated to enabling pharmaceutical and life sciences… | $2M | 103 mo ago | 20 | — | — | — | — | — |
| 25 | Hager Biosciences Biopharmaceutical company providing pre-clinical therapeutic leads through agile drug discovery chemistry | $2M | 25 mo ago | 3 | Bel Mekonnen President & CEO | — | — | 39 patents Small-molecule orexin and kappa‑opioid receptor modulators for neuropsychiatric therapies | — |
| 26 | Carmolex Provider of solutions for small molecule protein antagonists drug discovery | $2M | 151 mo ago | — | Carlos Camacho Co-Founder | — | — | — | — |
| 27 | PredxBio Developer of a platform for tissue-based biomarker discovery and clinical trials | $1M | 34 mo ago | 13 | Jeffrey Fine Co-Founder | WordPressMySQLPHP+24 | Top 50M | — | — |
| 28 | QuantumBio Bioinformatics solutions for drug discovery | $1M | 120 mo ago | 5 | Lance Westerhoff Founder | — | — | 7 patents Quantum‑enhanced X‑ray crystallography and cryo‑EM for high‑resolution protein structure analysis | — |
| 29 | ChemImage ChemImage produces innovative hyperspectral imaging systems with applications in the threat detection… | $1M | 83 mo ago | 91 | Myles Berkman CEO | — | — | 702 patents Molecular chemical/hyperspectral imaging for medical diagnostics and substance detection | — |
| 30 | Innovative Supply Solutions Clinical drug supply chain software and services | $500K | 45 mo ago | 13 | Adam Warren President & CEO | — | — | — | — |
| 31 | Biosignal Analytics Develops software to enhance EEG signals | $448K | 119 mo ago | — | Joe Camaratta Co-Founder & President | — | — | — | — |
| 32 | SCRIPT Biosciences Provider of gene-editing platform for drug development | $274K | 24 mo ago | 5 | Anil Namboodiripad CEO | — | — | — | — |
| 33 | SwiftSCIENCE Video-based mouse home cage monitoring technology for laboratory animal management | $200K | 73 mo ago | 5 | Nachi Pendse Co-Founder | — | — | — | — |
| 34 | CRO Analytics Cloud-based software for clinical research management | $175K | 124 mo ago | 19 | — | — | — | — | — |
| 35 | Vital Trax Accelerating clinical research enrollment through patient-centric solutions and supportive communities | $150K | 110 mo ago | 17 | — | — | — | — | — |
Top 12 Life Sciences Tech companies in Pennsylvania
#1
Series A · Merion, Pennsylvania · founded 2015 · 43 employees$6.7Mraised▾
Provider of compliance automation software for pharmaceutical industries. The company offers compliance solutions to support the drug and device supply chain which include initial assessments, obtaining new licenses, ongoing renewals, and state compliance filings.
- Mar 2026Series A$7.9M
- Jun 2023Series A$6.7M
- Nov 2021Seed$500K
#2
Series C · Philadelphia, Pennsylvania · founded 2014 · 85 employees$79.2Mraised▾
Proscia’s is a cloud-based software platform that clinic management, analysis, access, and collaboration for slide images in digital pathology. The features of the Proscia platform that allow users to improve whole slide image workflows include secure storage, annotation, and collaboration on digital biopsies. The company has developed a digital pathology platform called Concentriq that uses AI technology for computational pathology applications. The company has developed a tool that assists helathacre providers to diagnose cancer cells using image analysis technology.
- Mar 2025Series C$50M
- Dec 2023Series C$9M
- Jun 2022Series C$37M
- Nov 2020Series B$23M
#3
Series A · Malvern, Pennsylvania · founded 2002 · 13 employees$12Mraised▾
Developing innovative therapeutics targeting protein degradation for challenging diseases. The company is focused on advancing a new class of medicine through Molecular Glues and targeted protein degradation. Their platform leverages the ubiquitin system to develop therapies for challenging diseases, including neurodegenerative diseases like Parkinson’s and Alzheimer’s, cardiovascular disorders, metabolic dysfunction, and aging-related conditions. The company is engaged in drug discovery, delivering a pipeline of first-in-class therapeutics. They are exploring partnerships to further their reach and impact in the pharmaceutical industry. Their research focuses on areas like mitochondria, the Ubiquitin Proteasome System (UPS), and phospho-ubiquitin to restore mitochondrial functions and address diseases. The company is committed to innovation and redefining treatment paradigms through targeted protein degradation.
- May 2025Grant (prize money)$302.4K
- 2024Grant (prize money)$269.6K
- 2022Grant (prize money)$551.5K
- 2021Grant (prize money)$266K
#4
Series A · Blue Bell, Pennsylvania · founded 2020$5.5Mraised▾
Drug discovery platform developing peptide molecules. The company focuses on developing Spiroligomer molecules, a novel chemical platform for targeted drug discovery and applications in diagnostic testing cell permeability, and affordability in development.
- Sep 2025Series A$5.5M
#5
Series A · Philadelphia, Pennsylvania · founded 2019$4.5Mraised▾
Provider of AI operating system that accelerates the identification and development of the most promising drug candidates
- Mar 2025Series A$6.6M
- Nov 2023Seed$4.5M
#6
Series A · Pittsburgh, Pennsylvania · founded 2018 · 20 employees$55Mraised▾
Developer of a drug discovery platform for cancer therapies. The company has developed a proprietary computational platform for single-cell RNA-based analysis of high-quality, human tumor samples. The company’s pipeline includes three programs representing the next generation of immuno-oncology targets and drug candidates.
- Dec 2023Series A$15M
- Jul 2022Series A$40M
#7
Series A · Pittsburgh, Pennsylvania · founded 2017 · 31 employees$25.8Mraised▾
The company provides Regulatory Information Management (RIM) software for medical technology companies. The software consolidates all the functions of regulatory affairs, making product registration, standards management, essential principles/GSPR, and regulatory intelligence easy. The software solution has features for regulatory affair automation, navigation, digitalization, and monitoring.
- Mar 2024Series A$5.3M
- Dec 2021Series A$16M
- Mar 2021Series A$3M
- Aug 2020Seed$1.5M
#8
Series A · Philadelphia, Pennsylvania · founded 2020 · 7 employees$115Mraised▾
Online genetic engineering tool for drug development. The company focused on developing in vivo gene insertion therapies for the treatment of rare pediatric liver diseases including ARCUS a mediated therapeutic candidate.
- Nov 2022Series A$65M
- Sep 2021Series A$50M
#9
Acquired · Langhorne, Pennsylvania · founded 2003 · 87 employees$176.5Mraised▾
Aprecia Pharmaceuticals develops and manufactures orodispersible tablets with a focus on high-dose medications using ZipDose Technology. ZipDose Technology utilizes its proprietary three-dimensional printing (3DP) platform. This process stitches together multiple layers of powdered medication using an aqueous fluid to produce a porous, water-soluble matrix that rapidly disintegrates with a sip of liquid. FDA has recently approved SPRITAM levetiracetam for oral use as a prescription adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures in adults and children with epilepsy. SPRITAM utilizes its proprietary ZipDose Technology platform to produce a porous formulation that rapidly disintegrates with a sip of liquid. It plans to introduce multiple new products utilizing ZipDose Technology, focusing first on the central nervous system therapeutic area.
- Jul 2016Venture Debt$20M
- Jan 2016Series D$79M
- Aug 2015Series D$38.8M
- Dec 2013Series C$14.9M
#10
Seed · Philadelphia, Pennsylvania · founded 2018 · 5 employees$5.7Mraised▾
Panorama Medicine provides drug discovery platform. The company designed a platform that integrates genomics, big data, and computing to develop therapeutic interventions for RNA defects in disease. The platform helps in end-to-end, data production and analysis through validation of discoveries.
- Sep 2023Grant (prize money)$333.8K
- Jan 2021Seed$2M
- Jun 2019Seed$3.7M
- Sep 2018Conventional Debt$500K
#11
Funding Raised · Bethlehem, Pennsylvania · founded 2008 · 3 employees$1.8Mraised▾
Biopharmaceutical company providing pre-clinical therapeutic leads through agile drug discovery chemistry platforms. They offer unique small fragment molecules, improvement of drug-like properties, rapid med chem lead generation and optimization, and drug rescue. They focus on discovering licensable pre-clinical leads for unmet medical needs through collaborative partnerships. Their services include lead generation, optimization, profile improvement, methodology development, and project management. They are a preclinical-stage drug discovery organization based on innovative medicinal chemistry capabilities, aiming to be a preferred partner to pharmaceutical and biotech firms by providing therapeutic leads through out-licensing. Their discovery platform provides a competitive advantage for rapid medicinal chemistry optimization and intellectual property enhancement.
- May 2024Grant (prize money)$500K
- Sep 2015Grant (prize money)$225K
- Aug 2013Grant (prize money)$374.5K
- 2013Grant (prize money)$374.5K
#12
Acquired · Conshohocken, Pennsylvania · founded 2012 · 302 employees$40Mraised▾
Suvoda offers a clinical trial management solution. Its system called Suvoda IRT has solutions for drug supply management, reporting, and analysis. It can be used to visualize trial data, trends, performance (current and historical), and has a reusable library feature with modular system architecture. A modular system architecture enables the services team to select modules from a central library, configure them for a specific study, and create new modules to meet unique study-specific needs.
- Dec 2019Series C$40M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Pennsylvania is moving
A read on the academic research around Biotechnology in Pennsylvania — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 132 papers.
University of Pennsylvania and Penn State lead Pennsylvania's biotechnology research, optimistically advancing CAR-T cell therapy, RNA interference, and virus-based gene therapy with growing recent momentum.
- University of Pennsylvania76
- Pennsylvania State University52
- California University of Pennsylvania8
- Hospital of the University of Pennsylvania2
- Messenger RNA1→6
- Translation (biology)1→3
- In vivo1→3
- Gene2→4
- Agriculture3
- Processivity2
- Proliferating cell nuclear antigen2
- Clamp2
- DNA polymerase2
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.